On November 14, 2025, 5AM Venture Management, LLC disclosed it sold out its entire MoonLake Immunotherapeutics (MLTX) stake, reflecting an estimated $13.33 million net position change.
Adam Palasciano has no positions in any of the stocks mentioned. The Motley Fool has positions in and recommends Centessa Pharmaceuticals Plc. The Motley Fool recommends Viking Therapeutics. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback